CWM
CRNX icon

CIBC World Markets’s Crinetics Pharmaceuticals CRNX Stock Holding History

CIBC World Markets’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$278K Buy
+5,982
New +$266K ﹤0.01% 990
2025
Q2 		$320K Sell
11,142
-9,193
-45% -$284K ﹤0.01% 1073
2025
Q1 		$682K Buy
20,335
+12,129
+148% +$453K 0.01% 850
2024
Q4 		$420K Buy
+8,206
New +$459K ﹤0.01% 798

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIBC World Markets's CRNX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Crinetics Pharmaceuticals (CRNX) in Q4 2025: 5,982 shares worth $278K. The stake represents ﹤0.01% of the portfolio and ranks #990 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in CRNX as recently as Q2 2025.

CIBC World Markets first reported a position in CRNX in Q4 2024 and has held it in 4 quarters since. The position peaked at $682K in Q1 2025. 240 funds tracked by Wall St. Rank hold CRNX as of Q4 2025.

  • CIBC World Markets held 5,982 shares of Crinetics Pharmaceuticals worth $278K as of Q4 2025.
  • Crinetics Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Crinetics Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #990 holding.
  • CIBC World Markets first reported a position in Crinetics Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Crinetics Pharmaceuticals position peaked at $682K in Q1 2025.
  • 240 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.